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ABSTRACT
The Effects of 24R, 25-Dihydroxyvitamin D3 and 24S, 25-Dihydroxyvitamin D3 on
Phosphate Transport in Vivo

by
Yu Meng, Master of Science
Utah State University, 2011

Major Professor: Dr. Ilka Nemere
Department: Nutrition, Dietetics and Food Sciences
The steroid hormone 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] rapidly
stimulates the uptake of phosphate in isolated chick intestinal cells, while the steroid
24,25-dihydroxyvitamin D3 [24,25(OH)2D3] inhibits the rapid stimulation by
1,25(OH)2D3. Previous work in this laboratory has indicated that 24,25(OH)2D3 inhibits
phosphate uptake in isolated intestinal cells and perfused duodenal loops. It is critical to
show this effect in the whole animal to determine the presence of any confounding
factors. Studies were therefore undertaken to determine if 24,25(OH)2D3 had a similar
effect in vivo. 24,25(OH)2D3 has two isomers which are 24R, 25dihydroxyvitamin D3
[24R,25(OH)2D3] and 24S, 25dihydroxyvitamin D3 [24S,25(OH)2D3]. We studied these
two isomers separately and tested them over a time course of 1, 5, 10, 15, and 18 h after
steroid using chicks on regular diet, but fasted, and chicks on a lower vitamin D diet. All
chicks were anesthetized prior to surgical exposure of the duodenal loop and injection of
a solution containing H332PO4 into the lumen. An initial time course study of phosphate
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transport determined that 3 to 9 min of absorption in vivo was in a linear range, as judged
by serum levels of radioactivity. Chicks were then injected with either 200 µg of
24R,25(OH)2D3, 20 µg of 24S,25(OH)2D3, or vehicle for control groups within the same
time course studies. We found that the isomers had different effects on phosphate
absorption. 24R,25(OH)2D3 had a hypophosphatemic effect in vivo. The serum levels of
radionuclide revealed hypophosphatemic effects at 1, 5, 15, and 18 h time points with a
decrease of 20%, 42%, 39%, and 43%, respectively, (P< 0.05) compared with controls;
chicks raised on a low vitamin D diet also showed a decrease in phosphate absorption at
10 h time point by 33%. In contrast, 24S,25(OH)2D3 stimulated intestinal phosphate
absorption at the 5-h time point by 64%, but had no other effects at the other time points
tested. Because 24S,25(OH)2D3 was largely ineffective, dose-response studies were
undertaken with only the 24R,25(OH)2D3 isomer. In comparing phosphate absorption in
chicks fasted 18 h, and dosed with vehicle, 100 µg, 200 µg, or 300 µg of steroid 1 h prior
to experimentation it was found that the lowest dose increased absorption to 99% of
controls, while the 200 µg and 300 µg doses decreased phosphate absorption.
(48 pages)
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PUBLIC ABSTRACT
The Effects of 24R, 25-Dihydroxyvitamin D3 and 24S, 25-Dihydroxyvitamin D3 on
Phosphate Transport in Vivo
This research studied the effects of the two isomers of 24,25(OH)2D3 on
phosphate absorption in vivo to increase our understanding of the effects of
24,25(OH)2D3 on phosphate transport in vivo, and its two isomers. The current work
demonstrates that 24R,25(OH)2D3 is capable of decreasing phosphate absorption after a
1h injection in vivo and 24S,25(OH)2D3 can increase phosphate absorption after a 5h
injection, but this stimulation disappears at time points after 5h.
Since 24,25(OH)2D3 is made in vitamin D-replete animals, the observation that
24R,25(OH)2D3 decreases phosphate absorption suggests that over supplementation of
feeds with vitamin D may be counterproductive. Whether or not the unexpected
observation that 24S,25(OH)2D3 briefly stimulates absorption off sets this inhibition is
unknown. It is also likely that a lower level of supplementation with vitamin D would be
adequate for bone growth. Thus, appropriate levels of vitamin D supplementation may
result in more efficient utilization of phosphate in the diet, which would provide the
benefits of reducing feed costs and reducing phosphorous excretion, thereby contributing
to the sustainability of agriculture in the United States. Finally, these studies have
implications for bone health in all animals, including humans to prevent rickets in
children and osteoporosis in adults.

	
   vi
ACKNOWLEDGMENTS
I would like to thank Dr. Nemere for her support and mentoring during my
research and thesis. Her influence in my graduate studies inspired me to further my
education in nutrition. Dr. Nemere has ambition and determination that is uncommon
among most scientists. Her hard work has earned my admiration and utmost respect. I
would especially like to thank my committee members, Dr. Korry Hintze and Dr. Robert
E Ward, for their support and assistance throughout the entire process as well as adding
to my education throughout my course of study.
I also would like to express my thanks to my friends Xu Xu, Tremaine, and Yang
Zhang, for their help and sincere friendship.
I give special thanks to my mother, Zhen Zhong, and my father, Qingyu Meng,
for their encouragement, supports, and patience they allowed me to work on this research,
coursework, and thesis. I could not have done it without all of you. Thank you.
Yu Meng

	
   vii
CONTENTS
Page
ABSTRACT ...................................................................................................................... iii
PUBLIC ABSTRACT ........................................................................................................ v
ACKNOWLEGMENTS .................................................................................................... vi
LIST OF TABLES ........................................................................................................... viii
LIST OF FIGURES ........................................................................................................... ix
CHAPTER
I

INTRODUCTION ...................................................................................... 1

II

LITERATURE REVIEW ........................................................................... 3

III

MATERIALS AND METHODS .............................................................. 12

IV

RESULTS ................................................................................................. 14

V

DISCUSSION ........................................................................................... 24

REFERENCES ................................................................................................................. 27
APPENDICES .................................................................................................................. 34
A
B

Abbreviations ............................................................................................ 35
Statistical Analyses ................................................................................... 37

	
  viii

LIST OF TABLES
Table
1

Page
Vitamin D metabolite action summary ................................................................... 5

	
   ix
LIST OF FIGURES
Figure

Page

1

24, 25(OH)2D3 feedback loop ................................................................................. 4

2

Model of endocrine feedback of 24, 25(OH)2D3
on the rapid action of 1, 25(OH)2D3. ..................................................................... 9

3

Time course study of 32P transport in chick intestine ........................................... 15

4

Time course of 24R,25(OH)2D3 effect on 32P transport
in chick intestines with variable times of fasting .................................................. 16

5

Time course of 24S,25(OH)2D3 effect on 32P transport
in chick intestines with variable times of fasting .................................................. 17

6

Time course of 24R,25(OH)2D3 effect on 32P transport
in chick intestines with a constant 18 hours of fasting. ........................................ 18

7

Time course of 24S,25(OH)2D3 effect on 32P transport
in chick intestines with a constant 18 hours of fasting. ........................................ 19

8

Fig. 8. Dose-response study of 24R,25(OH)2D3 effect on 32P transport in chick
intestines with a constant 18 hours of fasting ...................................................... 21

9

Time course of 24R,25(OH)2D3 effect on 32P transport in chick
raised on a low vitamin D diet but not fasted ....................................................... 22

10

Time course of 24S,25(OH)2D3 effect on 32P transport in chick
raised on a low vitamin D diet but not fasted ....................................................... 23

CHAPTER I
INTRODUCTION
Vitamin D is metabolized in the liver to 25-hydroxyvitamin D3, and in the kidney
to 1,25-dihydroxyvitamin D3 [1,25(OH)2D3 ] and 24,25-dihydroxyvitamin D3
[24,25(OH)2D3]. 1,25(OH)2D3 is well known for its hormonal activity in diverse cell
types, and its ability to enhance intestinal calcium and phosphate absorption. By
comparison 24,25(OH)2D3 has not been as widely studied. However, a growing body of
literature has indicated that 24,25(OH)2D3 has important effects in development of bone
mass. Somjen et al. [1983] reported that 24R, 25(OH)2D3 but not 24S, 25(OH)2D3 was
active in bone while Ono et al. [1996] reported 24, 25(OH)2D3 is found in fracture
calluses in bone [Henry and Norman, 1978; Somjen et al., 1983; Ono et al., 1996].
One goal in poultry production is to increase the amount of meat on animals,
which in turn requires sufficient support of bone structure. To date, strategies for
improving bone strength have included increasing dietary calcium and phosphate, as well
as vitamin D. Knowing the effects of 24,25(OH)2D3 on phosphate and calcium
absorption in vivo has great significance to approaching this goal. Previous work in our
lab [Nemere, 1996a] indicated that 24R,25(OH)2D3 inhibits the rapid stimulation of
calcium and phosphate transport mediated by 1,25(OH)2D3 in isolated chick intestinal
cells and perfused duodenal loops. In addition Toffolon et al. [1975] found that
24,25(OH)2D3 decreased calcium absorption in dogs and Maeda et al. [1987] reported
that it caused hypocalcemia in rats. However the effects of 24,25(OH)2D3 on phosphate
transport in vivo remain unknown [Akiko et al., 1997].
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The current study was undertaken to determine whether 24R, 25(OH)2D3 or 24S,
25(OH)2D3 alters phosphate transport in the whole animal and if there is any
confounding factor present in vivo.
After establishing a time for linear transport in vivo, the experiments are designed
in four parts.
#1 Chicks were raised on regular diet with variable times of fasting before experiments.
They were then injected with 24R,25(OH)2D3 or 24S,25(OH)2D3 at different time points
(1, 5, 10, 15, and 18 h) before experimentation and effects on phosphate transport
analyzed.
#2 Chicks were raised on regular diet with a constant period of fasting before
experimentation and they were then injected with 24R,25(OH)2D3 or 24S,25(OH)2D3 at
different time points (1, 5, 10, 15, and 18 h) before experimentation and then the effects
of the metabolites tested on phosphate transport.
#3 Chicks were raised on a low vitamin D diet without a constant 18 h of fasting before
experiments. They were then injected with 24R, 25(OH)2D3 or 24S, 25(OH)2D3 at
different time points (1, 5, 10, 15, and 18 h) before experimentation and then the effects
of the metabolites tested on phosphate transport.
#4 After determining the optional time for observing steroid affects on phosphate
transport, does-response studies were undertaken. Range finding were accomplished with
does of 100, 200, and 300 µg 24R,25(OH)2D3.
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CHAPTER II
LITERATURE REVIEW
Background
Vitamin D was discovered because of a disease named rickets in young animals;
in adults this condition is known as osteomalacia. Professor Francis was the first to
describe vitamin D deficiency as rickets in 1650. Rickets is now known as softening and
weakening of the bone which results in leg bones bowing under the weight of children's
upper torsos. This disease became the key to discovering vitamin D, which was
considered a new nutritional factor [Hess, 1922; Mohr et al., 2008]. It was not initially
realized that, unlike other vitamins, humans could synthesize vitamin D through exposure
to UV light and did not require it in the diet, which meant vitamin D did not meet the
definition of a vitamin. In addition, vitamin D metabolites can function through binding
to specific protein receptors such as vitamin D receptor (VDR) or the 1,25D3-MARRS
(membrane associated rapid response steroid binding) receptor to mediate calcium and
phosphate transport. So 1,25(OH)2D3 is more like a hormone rather than a vitamin.
Vitamin D is also named cholecalciferol in animals and ergocalciferol in plants
and yeast in its inactive state. To become active cholecalciferol, it must be converted into
25(OH)D3 in the liver where it is hydroxylated at carbon-25. Then in the kidney,
25(OH)D3 is either hydroxylated at carbon-1 or carbon-24 to form the hormonally active
secosteroids 1,25(OH)2D3 and 24,25(OH)2D3, respectively, to function at target organs
such as bone, intestine and kidney. Figure 1 shows the feedback inhibition by 24,
25(OH)2D3.
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Fig. 1. 24, 25(OH)2D3 feedback loop.

Mechanisms of biological action of
vitamin D metabolites
The three active metabolites of vitamin D are 25(OH)D3, 1,25(OH)2D3 and
24,25(OH)2D3 (see Table 1 below for summary of metabolites). They play an important
role in calcium and phosphate homeostasis in the body.
1,25(OH)2D3 is the most well studied metabolite of vitamin D. A major function
of 1,25(OH)2D3 is to enhance serum calcium and phosphate concentrations [Bachelet et
al., 1979]. This is accomplished by its action on three organ systems.
The first is intestine where it acts to enhance the dietary absorption of calcium and
phosphate [Corradino and Wasserman, 1968]. Second, in the kidney, it stimulates
reabsorption [Khanal and Nemere, 2007]. Third is in the bone to enhance the resorption
and storage of these two minerals. The production and degradation of 1,25(OH)2D3 are
processes regulated by feedback mechanisms resulting from ionic (Ca2+, PO4-),
polypeptide hormones (PTH, calcitonin, FGF-23), and steroid factors [Bourdeau et al.,
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1990; Rohe et al., 2007; Khanal and Nemere, 2008]. Nemere [1996b] has found that
modulation of calcium and phosphate transport in the epithelia by 1,25(OH)2D3 acts both
through genomic and membrane-initiated actions. While the genomic regulation of
phosphate homeostasis is mediated through the well-known vitamin D receptor (VDR)
system; pre-genomic regulation involves the 1,25D3-MARRS receptor also identified as
ERp57 and PDIA3 [Larsson and Nemere, 2003; Khanal et al., 2007; Tunsophon and
Nemere, 2010]. In part, the nuclear action of 1,25(OH)2D3 functions through the classical
vitamin D receptor (VDR). VDR is a member of the nuclear receptor family of
transcription factors.
Table 1. Vitamin D metabolite action summary
Metabolite

Reference

25(OH)D3

Site
of Proposed action
activation
Liver
Increased CA2+
uptake in rat and
chick duodena

1, 25(OH)D3

Kidney

Increased
phosphate uptake
and transport in
intestine

Zhao and Nemere. 2002. 1,25(OH)D3mediated phosphate uptake in isolated
chick intestinal cells: effect of 24,
25(OH)D3, signal transduction
activators, and age. J. Cell Biochem.
86(3): 497-508

24,25(OH)D3

Kidney

Decreased
phosphate uptake
in presence of 1,
25(OH)D3
in
intestine

Nemere. 1996a. apparent non-nuclear
regulation of intestinal phosphate
transport effects of 1,25dihydroxyvitamin D3, 24,25dihydroxyvitamin D3, and 25hydroxyvitamin D3. Endocrinology.
137(6):2254-61

Olson and Deluca. 1969. 25hydroxycholecalciferol; direct effect on
calcium transport. Science.
165(891):405-7
Sterling and Nemere 2005
Seroids72:158-164
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Upon activation by 1,25(OH)2D3, the VDR forms a heterodimer with the retinoidX receptor (RXR) and binds to vitamin D response elements (VDRE) on DNA resulting
in expression or trans repression of specific gene products. These biological effects are
achieved after a relatively long time.
Another receptor is the 1,25D3-MARRS protein which can mediate the rapid
action of 1,25(OH)2D3 [Nemere et al., 1994]. This separate membrane receptor was
isolated from chick intestinal basal lateral membranes and was functionally linked to the
rapid uptake of phosphate in intestinal cells by using ribozyme knockdown [Nemere et
al., 2004.] A number of observations have contributed to the identification of a receptor
different from the VDR. One of the observations is that vitamin D analogs that have
limited ability to bind to the classical VDR can still stimulate the rapid actions analogous
to those of 1,25(OH)2D3 [Nemere and Norman, 1988]. Steroid hormone stimulated rapid
uptake and transport of calcium and phosphate is mediated by the 1,25D3-MARRS
protein. Receptor-ligand binding then activates the PKC pathway to stimulate phosphate
uptake while the PKA pathway mediates calcium uptake [Nemere, 1996c; Rohe et al.,
2005].
Functions attributed to 1,25(OH)2D3 other than mineral ion homeostasis include
regulation of gene transcription, promotion of cell proliferation, and stimulation of the
immune system [Khanal and Nemere, 2009; Richard et al., 2010; Wu et al., 2010].
Olson and Deluca [1969] reported that 25(OH)D3 could increase calcium uptake
in rat and chick duodena. Also Nemere [1996c] found that in perfused duodenal loops the
mono-hydroxylated metabolite failed to stimulate phosphate transport at normal
circulating levels and also abolished the stimulatory response to 1,25(OH)2D3, while at 5-
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fold lower than normal levels of 1,25(OH)2D3 the appearance of 32P in the venous
effluent was stimulated. This may represent an adaption or protective mechanism for
organisms experiencing vitamin D deficiency [Phadnis and Nemere, 2003].
The metabolite 24,25(OH)2D3 is another active metabolite of vitamin D and is
produced when an animal is calcium, phosphate, and vitamin D replete and represents an
important feedback loop to provide a protective mechanism against excess 1,25(OH)2D3
[Larsson et al., 1995]. Nemere [1996b] has found that 24, 25(OH)2D3 suppresses a rapid
action of 1,25(OH)2D3 on phosphate and calcium transport in the chick intestine. At a
cellular level, 24,25(OH)2D3 has been found to inhibit the rapid membrane effects of
1,25(OH)2D3 on opening of calcium channels in osteoblasts and osteosarcoma cells
[Yukihiro et al., 1994; Khoury et al., 1995; Takeuchi and Guggino, 1996] and PKC
activation in chick enterocytes [Nemere, 1999]. 24,25(OH)2D3 has two isomers which
are 24R, 25Dihydroxyvitamin D3 and 24S,25-dihydroxyvitamin D3. The physiological
effect of the vitamin D metabolite 24R,25-dihydroxyvitamin D3 on human osteoblastic
cells was assessed. Physiological concentrations (10-9-10-8 M) of 24R, 25(OH)2D3
significantly increased the cyclic guanosine 5'-monophosphate (cGMP) content in the
human osteoblastic cells by approximately 200% in 5 to 15 min. In contrast, 24S, 25dihydroxyvitamin D3 had only a weak effect on the cGMP content, and 1,25dihydroxyvitamin D3 did not affect the content [Yoshimoto and Norman, 1986]. These
observations suggest that 24R, 25(OH)2D3 has a unique activity of increasing cGMP
content in osteoblastic cells, and that the increase in cGMP content may lead to the
cooperative effect of 24R, 25(OH)2D3 with 1, 25(OH)2D3 on osteocalcin synthesis. These
data support the hypothesis that 24R, 25(OH)2D3 has a physiological role in human
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bone and mineral metabolism.
Biological effect and mechanism of
24,25(OH)2D3 action
Evidence has shown that 24,25(OH)2D3 has distinctly different biological effects
and mechanisms from 1,25(OH)2D3. 24,25(OH)2D3 inhibits the rapid stimulation by
1,25(OH)2D3. Earlier work in the Nemere lab has indicated that a cellular binding protein
for 24,25(OH)2D3 is the enzyme the catalase [Larsson et al., 2006]. A functional
consequence of 24,25(OH)2D3 binding to catalase was found to be a decrease in enzyme
activity, with concomitant increase in H2O2 production [Nemere et al., 2006]. One
mechanism of inhibition was then found to be oxidation of the 1,25D3-MARRS receptor
and inhibition of 1,25(OH)2D3 binding [Nemere et al., 2006]. Antioxidant diets nearly
doubled phosphate absorption in vivo [Nemere et al., 2006]. Peery and Nemere [2007]
then proved the hypothesis that anti-oxidant conditions, such as an anti-catalase antibody
or excess exogenous catalase protein, could block the inhibitory action of 24,25(OH)2D3,
whereas pro-oxidant conditions, such as a triazole inhibitor of catalase activity, could
mimic the inhibitory action of the secosteroid. It was further recognized that H2O2 could
also influence the signal transduction pathway beyond ligand binding to the 1,
25(OH)2D3-MARRS receptor [Peery and Nemere, 2007].
The model for the interaction between the 1,25D3-MARRS receptor and catalase
is described in Fig. 2. Upon binding 1,25(OH)2D3, the 1,25D3-MARRS receptor
dimerizes and increases signal transduction through PKA for enhanced calcium uptake
and PKC for enhanced phosphate uptake. Feedback inhibition of this stimulatory pathway
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is initiated when 24,25(OH)2D3 binds to catalase, thereby decreasing enzymatic activity.
The increased H2O2 levels are known to inhibit stimulated ion uptake and in this way the
rapid stimulation by 1, 25(OH)2D3 is inhibited by 24, 25(OH)2D3.
Phosphate absorption and bone health
One of the most important roles of vitamin D is to maintain skeletal phosphate
balance by promoting phosphate absorption in the intestines, promoting bone resorption
by increasing osteoclast number, maintaining calcium and phosphate levels for bone
formation, and allowing proper functioning of parathyroid hormone to maintain serum
calcium and phosphate levels [Tatsuo, 2004; Adams and Hewison, 2010].

Fig. 2. Model of endocrine feedback of 24, 25(OH)2D3 on the rapid action of
1,25(OH)2D3.
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The reason why vitamin D deficiency can result in lower bone mineral density
and an increased risk of bone loss (osteoporosis) or bone fracture is because a lack of
vitamin D alters mineral metabolism in the body [Lips, 2010]. This suggests that
phosphate plays a very important role in bone health either in bone formation and bone
mineral density.
Phosphates are normally absorbed from food and are important chemicals in the
body. They are involved in cell structure, energy transport and storage, vitamin function,
and numerous other processes essential to health [Holick, 2005]. White et al. [2011]
tested the effect of oral phosphate and alendronate on bone mineral density when given as
adjunctive therapy to growth hormone replacement (GHR) in adult growth hormone
deficiency [Marry et al., 1976]. Phosphate and alendronate therapy given in combination
with GHR confer an advantage in terms of bone mineral density (BMD) increase.
Phosphate appears to exert its effect by increasing PTH target-organ action, whereas
alendronate acts primarily through reduction in bone resorption [Nemere, 2007]. It was
also recently reported that phosphorus has a unique role in bone formation and osteocyte
maturation recently. In addition phosphate levels in blood are also very important to heart
and kidney disease. And 24,25(OH)2D3 as a hormone that mediates phosphate absorption
is also important in bone health.
Hypothesis
The hypothesis to be tested is that 24,25(OH)2D3 decreases phosphate transport in
vivo. The experiments conducted to test the hypothesis:
1. Determining a period of linear phosphate absorption.
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2. Determining phosphate absorption with variable times of fasting in chicks on a normal
vitamin D diet.
3. Determining phosphate absorption after constant 18 h fasting in chicks on a normal
vitamin D diet.
4. Determining phosphate absorption with chicks on a low vitamin D diet, no fasting.
5. Dose-response studies of 24R,25(OH)2D3 on phosphate absorption with chicks on a
regular diet but fasted.
Thesis Proposal
With sufficient study results suggesting that there are pregenomic actions of 24,
25(OH)2D3 in vitro, I tested the hypothesis that 24, 25(OH)2D3 can also alter phosphate
transport in the whole animal and if its two isomers 24R,25(OH)2D3 and 24S,25(OH)2D3
have the same effects on phosphate transport in vivo. The specific aims were as follows:
1. To determine the effect of 24R,25(OH)2D3 on phosphate transport in chicks raised on
regular diet with variable or constant times of fasting before experiments.
2. To determine the dose-response of 24R,25(OH)2D3 on phosphate transport in chicks
raised on regular diet with a constant interval of fasting before experiments
3. To determine the effect of 24R,25(OH)2D3 on phosphate transport in chicks raised on
low vitamin D diet with variable times of fasting before experiments.
4. To determine the effect of 24S,25(OH)2D3 on phosphate transport in chicks raised on
regular diet with a variable or a constant interval of fasting before experiments.
5. To determine the effect of 24S,25(OH)2D3 on phosphate transport in chicks raised on
low vitamin D diet with variable times of fasting before experiments.

	
   12
CHAPTER III
MATERIALS AND METHODS
Animals and surgical procedures
Utah State University Institutional Animal Use and Care Committee approved all
procedures. White leghorn cockerels were obtained on the day of hatch (Privett Hatchery,
Portales, NM) and raised on a regular diet (800 IU vitamin D /kg) or low vitamin D diet
(200 IU vitamin D/kg) for 3 weeks prior to experimentation. On the day of use, chicks
were anesthetized with 0.3 ml Chloropent /100g of body weight (Fort Dodge
Laboratories, Fort Dodge, IA). The abdominal cavity was surgically opened and the
duodenal lumen injected with 1 ml Grey’s Balanced Salt Solution (GBSS, 119 mM
NaCL, 4.96 mM KCl, 0.22 mM KH2PO4, 0.89 mM Na2HPO4, 1.03 mM MgCl26H2O,
0.28 mM MgSO4 7H2O2, 0.9 mM CaCl2 2H2O buffered to PH 7.4) mixed with 1µCi
H332PO4 (GBSS; H332PO4 1000:1). An initial time course of phosphate transport
determined that 5 min transport period was within a linear range. After 5 min of
transport, blood was collected by decapitation before preparation of serum, and
radioactivity determined by liquid scintillation spectrophotometry.
In one set of experiments chicks were anesthetized with ether. Although no
significant differences were eventually found between results with ether or chloropent
anesthesia, ether was not used because of potential oxidant formation.
Time courses studies
The chicks were divided into three groups in each time course study. They were
injected with vehicle (1:1 ethanol: propanediol), 200 µg 24R,25(OH)2D3 [Maeda et al.,
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1987] in vehicle, or 20 µg 24S,25(OH)2D3 [Ishizuka et al. 1984] in vehicle several hours
before experimentation. The extended time course points were 1, 5, 10, 15, and 18 h.
During these time points the chicks were fed water only (the chicks which were on
regular diet had an 18 h fast before experiments).
Effect of 24R,25(OH)2D3 or 24S,25(OH)2D3 on 32P
uptake by intestine
After waiting for 5 min for phosphate transport, the blood was collected after
decapitation. The blood was collected in tubes, labeled, sealed and stored at 4oC
overnight for clot separation from serum. An aliquot of serum (200µl) was pipetted into
vials and scintillation fluid added. 32P was then determined by using liquid scintillation
spectrophotometry.
Dose-response studies
Chicks were divided into four groups with a constant fasting period of 18 h. They
were injected with vehicle (1:1 ethanol: propanediol), 100 µg 24R,25(OH)2D3 in vehicle,
200 µg 24R,25(OH)2D3 in vehicle or 300 µg 24R,25(OH)2D3 in vehicle 1 hour before
experimentation.
Statistical analyses
Statistical comparisons between treatment groups were made using ANOVA.
Statistical significance was set at P<0.05. Results are expressed as Mean + SEM for each
set of independent experiments. See Appendix B for a detailed summary of statistical
measures.
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CHAPTER IV
RESULTS
Linear transport range (3-12 min)
Figure 3 shows the results of experiments designed to determine a suitable time
point for 32P transport in intestine. Time course studies on 32P uptake in chick intestine
were undertaken with a range of time points (3, 6, 9 and 12 min). The results show a
linear increase of 32P in serum (R2 =0.9757) from 3 to 9 min, reflecting absorption, as
judged by serum levels of radioactivity. At 12 min there was a decrease in 32P level in
serum, most likely due to a decrease in available phosphate. Since phosphate uptake is
stably increasing from 3 to 9 min, 5 min was chosen as the phosphate transport time in
the subsequent experiments.
Phosphate absorption with variable times of
fasting in chicks on a normal vitamin D diet
Figure 4 illustrates the results of experiments designed to test whether
24R,25(OH)2D3 has a hypophosphatemic effect in vivo. In this series of experiments,
chicks were raised on regular diet for three weeks. Prior to the day of use, chicks (n=12)
in the control groups (absence of hormone) were injected with vehicle (1:1 ethanol:
propanediol) at selected hours before experimentation, and at the same time the chicks
(n=12) of the treated groups (with hormone) were injected with 24R,25(OH)2D3 in
vehicle. Before experimentation, chicks were only fed water. After the selected hours, all
chicks were anesthetized prior to surgical exposure of the duodenal loop and injection of
a solution containing H332PO4 into the lumen. According to the initial time course study,
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Fig. 3. Time course study of 32P transport in chick intestine. 18 chicks were divided into
four groups. They were anesthetized with 0.3 ml chloropent /100g of body weight. The
abdominal cavity was surgically opened and the duodenal loop injected with 1 ml GBSS
containing 1µCi of 32P. After waiting for (1) T=3 min (n=6); (2) T=6 min (n=6); (3) T=9
min (n=6); (4) T=12 min (n=3), blood was collected by decapitation. Serum from the
samples was obtained after storage at 4 C for several hours to allow clot formation and
radioactivity determined by liquid scintillation spectrophotometry. Data are presented as
mean + SEM.

after 5min of transport, serum levels of radioactivity were used to determined phosphate
absorption.The results show 1 h and 5 h after injection of 24R,25(OH)2D3 there was no
difference in phosphate absorption between the control and treated groups. A slight
inhibition was found at the10-hour time point; and a dramatic response was obtained at
15 and 18 h (Fig. 4) after steroid. Statistical comparison by ANOVA confirmed that
phosphate absorption in chick intestine was not different between control and treated
groups at 1, 5, and 10 time points, but at the 15- and 18-hour time points phosphate
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transport was significantly decreased by 24,25(OH)2D3 (P<0.05) by 33% and 25%,
respectively. Figure 4 further reveals that variable fasting times had an effect on
phosphate absorption, since the control group of 15 h was 2990.8 ± 431.6 cpm/200µl
serum while the 1 h was only 1184.7 ± 121.9 cpm/200µl serum, suggesting that food
consumption in general maybe a confounding factor for phosphate transport in vivo.
Figure 5 depicts the effects of 24S,25(OH)2D3 on phosphate transport in vivo with
variable fasting times. Conditions were the same as Fig. 4, but instead of injecting
24R,25(OH)2D3, 24S,25(OH)2D3 was injected prior to experimentation. No differences
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Fig. 4. Time course of 24R,25(OH)2D3 effect on 32P transport in chick intestines with
variable times of fasting. Chicks were divided into five groups, 24 in each group and each
group further divided into two groups, control (C, n=12) and treated (D, n=12). They
were raised on a regular diet (800 IU vitamin D /kg) generally for 3 weeks prior to
experimentation. On the day of use, chicks in control groups were injected with vehicle at
the indicated hours before experimentation and at the same time the chicks of the treated
groups injected with 24R,25(OH)2D3 in vehicle. After selected hours (1, 5, 10, 15, and
18h) of fasting, they were anesthetized with a 0.3 ml chloropent /100g of body weight.
The abdominal cavity was surgically opened and the duodenal loop injected with1 ml
GBSS containing 1µCi of 32P. After 5min, blood was collected by decapitation. Serum
from the samples was obtained after storage at 4 C for several hours to allow clot
formation and radioactivity determined by liquid scintillation spectrophotometry. Data
are presented as mean + SEM. C, vehicle control; D, 200µg 24R,25(OH)2D3.
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were observed between control and treated groups at any of the time points (P>0.2). Also,
in this figure, it is evident that there was a large range in phosphate absorption from 1 h
to 15 h, which further indicates that diet is one of the confounding factors in phosphate
transport. General nutrient uptake may affect gastrointestinal hormones (GI hormone),
which may increase the phosphate uptake. The increase in phosphate absorption in
controls at the later time points may be due to an increase in transporters at the brush
border surface.
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Fig. 5. Time course of 24S,25(OH)2D3 effect on 32P transport in chick intestines with
variable times of fasting. Chicks were divided into two groups, control and treated, 60 in
each group and each group further divided into four time groups, 1h (n=3), 5 (n=3), 10
(n=30), 15 (n=30). They were raised on a regular diet (800 IU vitamin D /kg) generally
for 3 weeks prior to experimentation. On the day of use, chicks in control groups were
injected with vehicle at the indicated times before experimentation, and at the same times
the chicks of the treated groups were injected with 24S,25(OH)2D3 in vehicle. After
selected hours (1, 5, 10, and 15 h) of fasting, they were anesthetized with 0.3 ml
chloropent /100g of body weight. The abdominal cavity was surgically opened and the
duodenal loop injected with1 ml GBSS containing 1µCi 32P. After 5 min, blood was
collected by decapitation. Serum from the samples was obtained after storage at 4 C for
several hours to allow clot formation and radioactivity determined by liquid scintillation
spectrophotometry. Data are presented as mean + SEM. C, vehicle control; D, 20µg
24S,25(OH)2D3.
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Phosphate absorption after constant 18 h fasting
in chicks on a normal vitamin D diet
Clearly the variable times of fasting had an impact on phosphate absorption (Figs.
4, 5). To exclude this confounding factor shown in Fig. 4 and Fig. 5, chicks in the next
series of experiments were raised on regular diet for three weeks but prior to use, they
were all fasted for 18 h before experimentation. In these studies, chicks were injected
with 24R,25(OH)2D3 or vehicle.
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Fig. 6. Time course of 24R,25(OH)2D3 effect on 32P transport in chick intestines with a
constant 18 hours of fasting. Chicks were divided into six groups, control (n=17), 1h
(n=7), 5 h (n=10), 10h (n=9), 15h (n=13) and 18h (n=15). They were raised on a regular
diet (800 IU vitamin D /kg) for 3 weeks prior to experimentation. On the day of use,
chicks in control groups were injected with vehicle 18 hours before experimentation at
the same time the chicks of the treated groups began fasting and were served only water.
At the indicated hours before experimentations chicks of the treated groups were injected
with 24R,25(OH)2D3 in vehicle. After selected hours (1, 5, 10, 15 and 18 h) they were
anesthetized with 0.3 ml /100g of body weight chloropent. The abdominal cavity was
surgically opened and injected with1 ml GBSS containing 1µCi 32P in the duodenal loop.
After 5 min of absorption, blood was collected by decapitation. Serum from the samples
was obtained after storage at 4 C for several hours and radioactivity determined by liquid
scintillation spectrophotometry. Data are presented as mean + SEM. *P<0.05, relative to
vehicle controls.
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Compared with Figs. 4 and 5, the range of 32P absorption is considerably less than
that depicted in Fig. 6. In addition, the 1 h and 5 h steroid treated groups also showed a
significant decrease (P<0.02) in phosphate transport relative to controls, instead of only at
15 h and 18 h. At 10 h 24R,25(OH)2D3 again failed to inhibit phosphate transport even
after 18 h of constant fasting before experimentation. As seen previously (Fig. 4),
however, 24R,25(OH)2D3 inhibited phosphate absorption at the 15- and 18-h time points
(Fig. 6) .
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Fig. 7. Time course of 24S,25(OH)2D3 effect on 32P transport in chick intestines with
constant 18 hours of fasting. Chicks were divided into six groups, control (n=12), 1 h
(n=9), 5 h (n=10), 10 h (n=8), 15 h (n=8) and 18 h (n=8). They were raised on a regular
diet (800 IU vitamin D /kg) for 3 weeks prior to experimentation. On the day of use,
chicks in control groups were injected with vehicle 18 h before experimentation and at
the same time the chicks of the treated groups began fasting and were only fed on water.
At selected hours before experimentation chicks of the treated groups were injected with
24S,25(OH)2D3 in vehicle. After selected hours (1, 5, 10, 15, and 18 h) they were
anesthetized with 0.3 ml chloropent /100g of body weight. The abdominal cavity was
surgically opened and the duodenal lumen injected 1 ml GBSS containing 1µCi 32P. After
5min of absorption, blood was collected by decapitation. Serum from the samples was
obtained after storage at 4 C for several hours and radioactivity determined by liquid
scintillation spectrophotometry. Data are presented as mean + SEM.
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In Fig. 7, a slight stimulation by 24S,25(OH)2D3 was found in the 1 h and 15 h
groups but this was still not significant when compared by ANOVA (P>0.05). After 18 h
constant fasting in chicks, 24S,25(OH)2D3 also failed to alter in phosphate transport in
vivo.
Dose-response studies of 24R,25(OH)2D3
After 18 h constant fasting in chicks, 24S,25(OH)2D3 failed to alter phosphate
transport in vivo (Fig. 7) whereas 24R,25(OH)2D3 decreased phosphate transport 1, 5, 15,
and 18 h after injection (Fig. 6). After determining the optimal time for observing steroid
affects on phosphate transport, dose-response studies of 24R,25(OH)2D3 were
undertaken. Chicks were injected with vehicle (1:1 ethanol: propanediol), 100 µg
24R,25(OH)2D3 in vehicle, 200 µg 24R,25(OH)2D3 in vehicle or 300 µg 24R,25(OH)2D3
in vehicle respectively 1 h before experimentation, and phosphate absorption was
determined from serum by liquid scintillation spectrophotometry. Results are shown in
Fig. 8. ANOVA confirmed that the 100 µg group exhibited an increased phosphate
absorption compared with control group (P<0.05). In the 100 µg group, phosphate
absorption increased by 99% compared with the chicks in control group. The stimulation
may be because lower level of 24R,25(OH)2D3 could affect Parathyroid hormone (PTH)
secretion [Nemere, 1996b] which further stimulates phosphate absorption.
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Fig. 8. Dose-response study of 24R,25(OH)2D3 effect on 32P transport in chick intestines
with a constant 18 hours of fasting. Chicks were raised on a regular diet (800 IU vitamin
D /kg) for 3 weeks prior to experimentation. Chicks were divided into four groups,
control (n=5), 100 µg (n=3), 200 µg (n=3) and 300 µg (n=). They were injected with
vehicle (1:1 ethanol: propanediol), 100 µg 24R,25(OH)2D3 in vehicle, 200 µg
24R,25(OH)2D3 in vehicle or 300 µg 24R,25(OH)2D3 in vehicle, respectively, 1 h before
experimentation. On the experimentation they were anesthetized with 0.3 ml chloropent
/100g of body weight. The abdominal cavity was surgically opened and injected with1 ml
GBSS containing 1µCi 32P in the duodenal loop. After 5min of absorption, blood was
collected by decapitation. Serum from the samples was obtained after storage at 4 C for
several hours and radioactivity determined by liquid scintillation spectrophotometry. Data
are presented as mean + SEM. *P<0.05, relative to vehicle controls.
Phosphate absorption with chicks on a low
vitamin D diet, no fasting
To further exclude the diet’s effect on phosphate absorption, chicks in this series
of experiments were raised on a low vitamin D diet for 3 weeks before the experiments
with no fasting before experimentation. Previous experiments showed 24R,25(OH)2D3
has a hypophosphatemic effect in vivo after 1, 5, 15, and 18 h following injection with 18
h constant fasting before experimentation. Figure 9 shows the results of absorption in
chicks raised on a low vitamin D diet, and ANOVA confirmed that the 1-h, 5-h, 10-h, and
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15-h groups all exhibited a decreased phosphate absorption compared with control groups
(P<0.02). In the 1-h group, phosphate absorption decreased by 50% compared with the
chicks that were raised on regular diet in which phosphate transport decreased by 30%.
However the latter decrease was not significantly different than control, which indicates
that the vitamin D level in the diet is one of the confounding factors that may affect
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Fig. 9. Time course of 24R,25(OH)2D3 effect on 32P transport in chick intestines in chicks
raised on a low vitamin D diet but not fasted. Chicks were divided into six groups,
control (n=12), 1 h (n=6), 5 h (n=9), 10 h (n=9), 15 h (n=10) and 18 h (n=8). They were
raised on a low vitamin D diet (200 IU vitamin D /kg) for 3 weeks prior to
experimentation. On the day of use, chicks of control groups were injected with vehicle
18 h before experimentation. At selected hours (1, 5, 10, 15, and 18 h) before
experimentation chicks of the treated groups were injected with 24R,25(OH)2D3 in
vehicle. On the day of experimentation they were anesthetized with 0.3 ml chloropent
/100g of body weight. The abdominal cavity was surgically opened and injected with 1
ml GBSS containing 1µCi 32P into the lumen of duodenal loop. After 5min, blood was
collected by decapitation. Serum from the samples was obtained after storage at 4 C for
several hours and radioactivity determined by liquid scintillation spectrophotometry. Data
are presented as mean + SEM. * P<0.05, relative to vehicle controls.
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Figure 10 illustrates the results of comparable experiments with chicks fed a low
vitamin D diet, and injected with 24S,25(OH)2D3 or vehicle. 24S,25(OH)2D3 stimulated
the phosphate transport at the 5-h time point after injection (P<0.05), but no significant
differences were observed at the other time points.
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Fig. 10. Time course of 24S,25(OH)2D3 effect on 32P transport in chicks raised on a low
vitamin D diet but not fasted. Chicks were divided into six groups, control (n=9), 1 h
(n=9), 5 h (n=9), 10 h (n=8), 15 h (n=9) and 18 h (n=10). They were raised on a low
vitamin D diet (200 IU vitamin D /kg) generally for 3 weeks prior to experimentation. On
the day of use, chicks of control groups were injected with vehicle 18 h before
experimentation. And the treated groups were injected with 24S,25(OH)2D3 in vehicle1,
5, 10, 15, and 18 h before experimentation. After selected hours (1, 5, 10, 15, and 18 h),
they were anesthetized with a 0.3 ml chloropent /100g of body weight. The abdominal
cavity was surgically opened and injected with 1 ml GBSS containing 1µCi of 32P into
the lumen of duodenal loop. After 5 min, blood was collected by decapitation. Serum
from the samples was obtained after storage at 4 C for several hours and radioactivity
determined by liquid scintillation spectrophotometry. Data are presented as mean + SEM.
* P<0.05, relative to vehicle controls.
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CHAPTER V
DISSCUSSION
The current work demonstrates that 24R,25(OH)2D3 is capable of decreasing
phosphate absorption after a 1-h injection in vivo and 24S,25(OH)2D3 can increase
phosphate absorption after a 5-h injection, but this stimulation disappears at the time
points tested after 5 h.
In previous reports, the enzyme catalase was proved to be a cellular binding
protein for 24,25(OH)2D3 [Larsson et al., 2006]. Catalase activity could be inhibited by
24,25(OH)2D3 and production of H2O2 increased in intestinal cells [Nemere et al., 2006].
Hydrogen peroxide, in turn, oxidizes thiols within the 1,25D3-MARRS receptor to
decrease binding of 1,25(OH)2D3, and also inhibit the rapid stimulation of the protein
kinase C signaling pathway [Peery and Nemere, 2007].
In the present study, it was found that the two isomers of 24,25(OH)2D3 had
different effects on phosphate transport in vivo suggesting that the inhibitory effect might
be mainly performed by 24R,25(OH)2D3 while 24S,25(OH)2D3 might have another
receptor or in some manner stimulate other pathways to mediate phosphate absorption in
vivo. Somjen et al. [1983] reported that 24R,25(OH)2D3 but not 24S,25(OH)2D3 was
active in bone. However, in this work, 24S,25(OH)2D3 was found to be active in chick
intestine in vivo and increased phosphate transport at 5h but this effect disappeared at 10
h and later time points.
Another observation is 24R,25(OH)2D3 decreased phosphate absorption after 1 h
indicating that the phosphate inhibition might not occur because of 24R,25(OH)2D3
binding to catalase or blocking the1,25D3-MARRS receptor. Previous work in the
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perfused duodenal loop system proved that the antagonism of the stimulatory effect of
1,25(OH)2D3 by 24,25(OH)2D3 was seen 10 min after the onset of perfusion [Nemere,
1996b]. There might be a separate nuclear receptor for 24,25(OH)2D3 which could induce
genomic change in cells resulting in a decreased absorption of phosphate after 1 h.
Another mechanism maybe catalase binding to STAT3 [Ndubuisi et al., 1999]. In
addition, this effect disappeared after 18 h. Alternatively, 24R,25(OH)2D3 might mediate
the production of separate hormones that regulate phosphate absorption, such as
fibroblast growth factor-23 (FGF 23) which is a recently identified member of the FGF
family involved in phosphate homeostasis [Razzaque et al., 2005].
Early work with isolated cells or perfused duodenal loops could not completely
apply in vivo because of potential confounding factors that have yet to be determined. In
the current work using individual chicks and studies of the effects of 24,25(OH)2D3 in
vivo, we found that the duration of fasting and vitamin D level in the diet were two
factors that had a major influence on phosphate absorption. The chicks fed on a low
vitamin D diet showed more significant decreases in phosphate transport than chicks fed
on regular diet. While chicks on the regular diet but with different fasting times had a
large range of serum phosphate values between each time point. The greater phosphate
absorption could be due to a generalized increase in nutrient absorption, in which
phosphate is bound to other components. Another possibility could be due to the release
and action of GI hormones. Also, the dose response experiment suggested low level of
24R,25(OH)2D3 could stimulate phosphate absorption while a higher level could not
increase phosphate absorption but decreased it instead. The stimulation could due to a
low level of 24R,25(OH)2D3 that may increase PTH secretion which led to increasing
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phosphate absorption in vivo [Nemere and Szego, 1981a; Nemere and Szego, 1981b]. As
noted earlier, the higher cpms at longer fasting times might be due to increased phosphate
transporters appearing at the brush border membrane.
This research increases our understanding of the effects of 24,25(OH)2D3 on
phosphate transport in vivo, and its two isomers. By understanding the action of these
two isomers, progress will be made in enhancing phosphate absorption in production
animals to supply the minerals for adequate bone growth. Moreover, more efficient
utilization of phosphate in the diet will provide the benefits of reducing feed costs and
reducing phosphorous excretion, thereby contributing to the sustainability of agriculture
in the United States. Also these studies have implications for bone health in all animals,
including humans to prevent rickets in children and osteoporosis in adults.
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µCi……………………..Microcurie, a term used to quantify radioactivity
µg………………………Micrograms
µl……………………….Microliter
1,25(OH)2D3…..………..1, 25-dihydroxyvitamin D3
1,25D3-MARRS………..1,25-dihydroxyvitamin D3 membrane-associated, rapid-response
receptor
steroid-binding protein
24R,25(OH)2D3…..……24R, 25-dihydroxyvitamin D3
24S,25(OH)2D3…..……24S, 25-dihydroxyvitamin D3
25(OH)2D3…..………….25-hydroxyvitamin D3
32

P……………………….Radioisotope of phosphorous from abbreviated notation of
H332PO4

ANOVA…………………Analysis of Variants
Ca2+……………………..Calcium
cpm/ µg………………….Counts per minute over micrograms of protein
GBSS……………………Gey’s Balanced Salt Solution
H2O2……………………..Hydrogen peroxide
mM………………………Millimolar.
P………………………….P-value statistical measure
PKA………………………Protein Kinase A
PKC………………………Protein Kinase C
SEM………………………Standard Error of Mean
T…………………………..Abbreviation of Time
VDR……………………….Vitamin D Nuclear Receptor
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Table A. ANOVA for figure 4. Time course of 24R,25(OH)2D3 effect on 32P transport in
chick intestines with variable times of fasting.
Time
1h C 1h D 5h C 5h D 10hC 10hD 15hC 15hD 18hC 18hD
Average 1184 1137
1272 1281
1954
1538
2990
2016
2341
1755
SE
121.8 171.5 222.1 232.5 265.2 230.3 431.6 73.7
207.3 284.9
DF
12
12
12
12
12
12
12
12
12
12
T test
0.22
0.028
1.19
2.23
1.67
P value
P>0.1
P>0.1
P>0.
P<.0
P<.0
1
5
5
Table B. ANOVA for figure 5. Time course of 24S,25(OH)2D3 effect on 32P transport in
chick intestines with variable times of fasting.
Time
1h C
1h D
5h C
5h D
10h C 10hD
15h C 15h D
Average 1043.2 1081.6
1081.6 1203.2 1999.4 2184
2105.8 2015.74
S.E.
332.8
128
371.2
140.8
280.96 220.96 322.56 289.68
DF
3
3
3
3
30
30
30
30
T test
0.11
0.31
0.52
0.21
P value
P>0.05
P>.05
P>.05
P>0.05
Table C. ANOVA for figure 6. Time course of 24S,25(OH)2D3 effect on 32P transport in
chick intestines with a constant 18 hours of fasting.
Time
Control
1h
5h
10h
15h
18h
Average
318.64
419.67
342.78
299.80
351.40
303.98
Standard Error
72.87
109.46
43.15
105.57
50.85
64.10
DF
12
9
10
8
8
8
T test
0.77
0.28
0.14
0.37
0.15
P value
P>0.2
P>0.2
P>0.2
P>0.2
P>0.2
Table D. ANOVA for figure 7. Time course of 24S,25(OH)2D3 effect on 32P transport in
chick intestines with a constant 18 hours of fasting.
Time
Control
1h
5h
10h
15h
18h
Average
318.64
419.67
342.78
299.80
351.40
303.98
Standard Error
72.87
109.46
43.15
105.57
50.85
64.10
DF
12
9
10
8
8
8
T test
0.77
0.28
0.14
0.37
0.15
P value
P>0.2
P>0.2
P>0.2
P>0.2
P>0.2
Table E. ANOVA for figure 8. Dose-response of 24R,25(OH)2D3 effect on 32P transport
in chick intestines at 1h.
Time
Control
100 µg
200 µg
300 µg
Average
131.12
261.20
98.90
85.33
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Standard Error
DF
T test
P value

18.09
5

22.19
3
3.32
P<0.05

17.7
3
1.15
P>0.05

16.37
3
1.86
P>0.05

Table F. ANOVA for figure 9. Time course of 24R,25(OH)2D3 effect on 32P transport in
chick intestines without fasting on a low vitamin D diet.
Time
Control
1h
5h
10h
15h
18h
Average
134.03
68.93
79.43
89.47
77.90
131.35
Standard Error
17.94
6.28
16.38
12.17
13.28
45.04
DF
12
6
9
9
10
8
T test
3.66
2.35
2.16
2.8
0.06
P value
P>0.2
P<0.05
P<0.05
P<0.05
P>0.2
Table G. ANOVA for figure 10. Time course of 24S,25(OH)2D3 effect on 32P transport in
chick intestines without fasting on a low vitamin D diet.
Time
Control
1h
5h
10h
15h
18h
Average
218.64
250.22
359.5
223.75
254.44
270.8
Standard Error
40.00
42.63
52.03
66.85
53.05
52.08
DF
9
9
9
8
9
10
T test
1.15
2.15
1.5
1.45
0.99
P value
P>0.2
P<0.05
P>0.2
P>0.2
P>0.2

